House Democrats Start Multiple Sclerosis Drug Price Probe

House Democrats have started what they called an "in-depth" investigation into the pricing of drugs for neurological condition multiple sclerosis, the latest attempt by U.S. politicians to pressure manufacturers to lower costs.

Seven drugmakers--Biogen, Sanofi, Novartis, Roche Holding, Bayer, Merck KGaA's EMD Serono unit and Teva Pharmaceuticals--received letters requesting information on pricing strategies from Elijah Cummings and Peter Welch, two representatives who sit on the House...

What feeling does this article give you?
Joy
Disgust
Fear
Anger
Sadness

#hashtags to follow:

House Democrats [+]    Biogen [+]    Sanofi [+]    Novartis [+]    Roche Holding [+]    Bayer [+]    Merck KGaA [+]    EMD Serono [+]    Teva Pharmaceuticals [+]   

More #news: